CPC A61K 31/444 (2013.01) [A61P 35/00 (2018.01); G01N 33/5038 (2013.01); A61K 45/06 (2013.01)] | 13 Claims |
1. A method of treating cancer in a mammalian subject in need thereof, said cancer contains cancer cells characterized by presence of wild type isocitrate dehydrogenase 1 (IDH1) enzyme and absence of mutant IDH1 enzyme, the method comprising
administering to said subject a pharmaceutical composition comprising compound AG-120 having the formula
![]() and
reducing glucose concentration in blood of said subject.
|